Xia Bu
Impact in
- Oncology top 0.5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
Papers in
- Oncology 20
- Cancer Immunotherapy and Biomarkers 18
- Cancer-related Molecular Pathways 1
-
- T-cell and B-cell Immunology 3
- Phagocytosis and Immune Regulation 2
- Co-authors
- Gordon James Freeman (14 shared papers)Deng Pan (1 shared paper)Xihao Sherlock Hu (1 shared paper)Myles Brown (1 shared paper)Peng Jiang (1 shared paper)Bo Li (1 shared paper)Kai W. Wucherpfennig (1 shared paper)Avinash D Sahu (1 shared paper)
- Journals
- Nature Communications (3 papers)The Journal of Immunology (2 papers)Cell Research (2 papers)Advances in experimental medicine and biology (2 papers)Blood (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Xia Bu
31 papers receiving 7k citations
Xia Bu's Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 3.4k
- Cancer Research 825
- Pulmonary and Respiratory Medicine 1.4k
- Immunology 778
- Hepatology 297
Countries citing papers authored by Xia Bu
This map shows the geographic impact of Xia Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Bu more than expected).
Fields of papers citing papers by Xia Bu
This network shows the impact of papers produced by Xia Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Bu. The network helps show where Xia Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response Hit paper breakdown → | 2018 | 3678 |
| 2 | Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance Hit paper breakdown → | 2017 | 839 |
| 3 | 2020 | 310 | |
| 4 | 2013 | 294 | |
| 5 | 2010 | 290 | |
| 6 | 2014 | 279 | |
| 7 | 2021 | 200 | |
| 8 | 2021 | 180 | |
| 9 | 2002 | 124 | |
| 10 | 2018 | 119 | |
| 11 | 2022 | 113 | |
| 12 | 2019 | 106 | |
| 13 | 2004 | 72 | |
| 14 | 2023 | 67 | |
| 15 | 2023 | 67 | |
| 16 | 2010 | 65 | |
| 17 | 2016 | 59 | |
| 18 | 2023 | 53 | |
| 19 | 2005 | 32 | |
| 20 | 2017 | 28 |
About Xia Bu
Xia Bu is a scholar working on Oncology, Immunology, Molecular Biology, Developmental Neuroscience and Epidemiology, having authored 31 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (18 papers), T-cell and B-cell Immunology (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers), Phagocytosis and Immune Regulation (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Cancer-related Molecular Pathways (1 paper), Cellular transport and secretion (1 paper) and Asthma and respiratory diseases (1 paper). The work is most often cited by research in Oncology (3.4k citations), Cancer Research (825 citations), Pulmonary and Respiratory Medicine (1.4k citations), Immunology (778 citations) and Hepatology (297 citations). Xia Bu has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Gordon James Freeman, Deng Pan, Xihao Sherlock Hu, Myles Brown, Peng Jiang, Bo Li, Kai W. Wucherpfennig, Avinash D Sahu, Jingxin Fu and Ziyi Li. Their work appears in journals such as Nature Communications, The Journal of Immunology, Cell Research, Advances in experimental medicine and biology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.